Although the 2020 WHO Classification documents ‘desirable’ criteria as positive expression of GATA-binding protein 3 (GATA3) and thyroid transcription factor (TTF1), with negative expression of hormone receptors [5], these are not sufficient for the reliable diagnosis of this rare tumor; the development of more effective diagnostic criteria is critical. This evidence concerns the gene NR4A1 and neoplasm.